Venture capital firm based in London, UK
Cambridge-based Owlstone Medical lands £36.5m from ARPA-H. Owlstone Medical's at-home multi-cancer test combines breath sampling and urine sampling to detect stage I cancers. Read more
| Healthtech | 71.4% |
| Fintech | 28.6% |